TrademarkDir
ACCULYSE
LIVE

Serial Number

98205862

Owner

Syncromune, Inc.

Attorney

Jessica L. Rothstein

Filing Date

Oct 2, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ACCULYSE Trademark

Serial Number: 98205862

ACCULYSE is a trademark filed by Syncromune, Inc. on October 2, 2023. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Syncromune, Inc. (9 trademarks)

2919 East Commercial Blvd.
Fort Lauderdale, FL 33308

Entity Type: 03

Trademark Details

Filing Date

October 2, 2023

Registration Date

Not Registered

Published for Opposition

April 16, 2024

Goods & Services

Medical devices for the treatment of solid tumor cancers which deliver direct injections of drugs into the tumor or to a localized region of the body causing tumor cell lysis; Medical apparatus, namely, infusion and injection devices for locally targeted drug administration

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 6, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jun 5, 2026 EX4G
SOU EXTENSION 4 FILED
Jun 5, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 5, 2026 EEXT
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 13, 2026 EPPA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2025 EXRA
SOU EXTENSION 3 GRANTED
Nov 6, 2025 EX3G
SOU EXTENSION 3 FILED
Nov 6, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 6, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 9, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 9, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 6, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 6, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 5, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 11, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 12, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 12, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 12, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 12, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 23, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2023 NWOS
NEW APPLICATION ENTERED
Oct 5, 2023 NWAP

Related Trademarks

More from this Owner

SYNCROVAX

SYNCROVAX

SYNC-T

SYNC-T

SYNC-T

SYNC-T

SYNCROVAX

SYNCROVAX

SYNCROVAX

SYNCROVAX

CANCER THERAPY POWERED BY YOU

CANCER THERAPY POWERED BY YOU